Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol
Open Access
- 14 September 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 901786
Abstract
Background: A previous study has shown similar factors in dyslipidemias (DL) and osteoporosis (OP). However, no cohort study has been reported on the association between DL and OP in the postmenopausal population in China. This study aims to provide epidemiological and pathophysiological evidence regarding the association between DL and bone mass and fracture risk.Methods: This is a multicenter, prospective cohort study that will have approximately 1,100 representative participants enrolled from multiple hospitals or communities in China. They will be divided into two groups according to whether or not they are exposed to dyslipidemia and will be epidemiologically investigated. Each participant will be visited continuously once every year with a minimum follow-up of 3 years to track incidences of OP. Meanwhile, free bone density screening, questionnaires, and blood sample collection will also be completed during this period.Conclusion: The current study is likely to provide greater insight into the relationship between lipid metabolism and bone metabolism in postmenopausal women. Furthermore, the research result maybe fed into public health strategies with regard to metabolic disease prevention.Keywords
This publication has 23 references indexed in Scilit:
- A possible regulatory link between Twist 1 and PPARγ gene regulation in 3T3-L1 adipocytesLipids in Health and Disease, 2016
- Relationship between Vitamin D Receptor Gene Polymorphisms, Cardiovascular Risk Factors and Adiponectin in a Healthy Young PopulationPharmacogenomics, 2016
- BMI and BMD: The Potential Interplay between Obesity and Bone FragilityInternational Journal of Environmental Research and Public Health, 2016
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transitionThe Lancet, 2015
- High Cholesterol Deteriorates Bone Health: New Insights into Molecular MechanismsFrontiers in Endocrinology, 2015
- Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 DiabetesEndocrine Practice, 2015
- Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liverTrends in Molecular Medicine, 2013
- Obesity and fracture in men and women: An epidemiologic perspectiveJournal of Bone and Mineral Research, 2011
- SNP–SNP interactions within APOE gene influence plasma lipids in postmenopausal osteoporosisRheumatology International, 2010
- Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScoresBMJ, 2009